• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】29338

【品名】1-propanol

【CA登记号】71-23-8

【 分 子 式 】C3H8O

【 分 子 量 】60.09592

【元素组成】C 59.96% H 13.42% O 26.62%

与该中间体有关的原料药合成路线共 5 条

合成路线1

该中间体在本合成路线中的序号:(B)

The ketalization of 2beta-ethoxy-3alpha-hydroxy-5alpha-pregnane-11,20-dione (I) with ethylene glycol (A) by means of p-toluenesulfonic acid in refluxing benzene gives the corresponding 20,20-ethylenedioxy derivative (II), which is treated with hydroxylamine hydrochloride and NaOH refluxing ethanol to yield 20,20-ethylenedioxy-2beta-ethoxy-3alpha-hydroxy-5alpha-pregnan-11-one 11-oxime (III). The reduction of (III) with Na in refluxing propanol (B) affords 11alpha-amino-20,20-ethylenedioxy-2beta-ethoxy-3alpha-hydroxy-5alpha-pregnan (IV), which is finally methylated with methyl iodide and K2CO3 or with formaldehyde and formic acid, and hydrolyzed with HCl or H2SO4.

1 Philips, G.H.; Ewan, G.; DE 2715078 .
2 Hillier, K.; Castaner, J.; Blancafort, P.; Serradell, M.N.; Minaxolone. Drugs Fut 1980, 5, 12, 614.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(AI) 11295 Polyethylene glycol;1,2-Ethanediol;Monoethylene glycol; Ethylene glycol 107-21-1 C2H6O2 详情 详情
(B) 29338 1-propanol 71-23-8 C3H8O 详情 详情
(I) 39209 (2S,3S,5S,8S,9S,10S,13S,14S,17S)-17-acetyl-2-ethoxy-3-hydroxy-10,13-dimethylhexadecahydro-11H-cyclopenta[a]phenanthren-11-one C23H36O4 详情 详情
(II) 39210 (2S,3S,5S,8S,9S,10S,13S,14S,17S)-2-ethoxy-3-hydroxy-10,13-dimethyl-17-(2-methyl-1,3-dioxolan-2-yl)hexadecahydro-11H-cyclopenta[a]phenanthren-11-one C25H40O5 详情 详情
(III) 39211 (2S,3S,5S,8S,9S,10S,13S,14S,17S)-2-ethoxy-3-hydroxy-10,13-dimethyl-17-(2-methyl-1,3-dioxolan-2-yl)hexadecahydro-11H-cyclopenta[a]phenanthren-11-one oxime C25H41NO5 详情 详情
(IV) 39212 (2S,3S,5S,8S,9S,10S,11R,13S,14S,17S)-11-amino-2-ethoxy-10,13-dimethyl-17-(2-methyl-1,3-dioxolan-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-3-ol C25H43NO4 详情 详情

合成路线2

该中间体在本合成路线中的序号:(III)

1,2-Epoxy-3-(2-cyanophenoxy)propane (I) is added to one equivalent of N-(2-aminoethyl)-4-benzyloxyphenylacetamide (II) in n-propanol and heated to reflux for 18 h, giving N-[2-(3-o-cyanophenoxy-2-hydroxypropylamino)ethyl]-4-benzyloxyphenylacetamide (III). Hydrogenolysis of the 4-benzyl moiety of (III) may be performed under mild conditions (e.g., hydrogen gas with palladium on carbon in ethanol at room temperature) to yield ICI-141292.

1 Large, M.S.; Smith, L.H.; Beta-adrenergic blocking agents. 22. 1-Phenoxy-3-[[(substituted-amido)alkyl]amino]-2-propanols. J Med Chem 1982, 25, 11, 1286.
2 Smith, L.H. (AstraZeneca plc); Alkanolamine derivatives. BE 0872820; FR 2412521; GB 1573359 .
3 Pento, J.T.; Day, B.W.; Epanolol. Drugs Fut 1985, 10, 5, 392.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 29336 2-(2-oxiranyloxy)benzonitrile C9H7NO2 详情 详情
(II) 29337 N-(2-aminoethyl)-2-[4-(benzyloxy)phenyl]acetamide C17H20N2O2 详情 详情
(III) 29338 1-propanol 71-23-8 C3H8O 详情 详情
(IV) 29339 2-[4-(benzyloxy)phenyl]-N-(2-[[3-(2-cyanophenoxy)-2-hydroxypropyl]amino]ethyl)acetamide C27H29N3O4 详情 详情

合成路线3

该中间体在本合成路线中的序号:(VIII)

Hydrogenation of D-4-hydroxyphenyl glycine (I) over Raney-Ni in NaOH affords 4-hydroxycyclohexylglycine (II), which is condensed with sulfonyl chloride (III) in dioxane in the presence of Et3N to yield derivative (IV). Carboxylic acid (IV) is converted into benzyl ester (VI) by treatment with benzyl bromide (V) by means of N,N'-dicyclohexylamine (DCHA) in DMF and (VI) is then oxidized by treatment with NaBr, 2,2,6,6-tetramethyl-1-piperidinyloxy free radical (TEMPO) and NaClO2 in CH2Cl2/H2O to provide ketone (VII). Condensation of (VII) with n-propanol (VIII) by means of PhSiH3 and TFA gives a mixture of compounds from which trans-(IX) is cromatographically separated. Then ketone (IX) reacts with 4-picolyl chloride (X) and K2CO3 in DMF to furnish compound (XI). Hydrogenation of benzyl acetate (XI) over Pd/C in EtOH/HCl affords acetic acid derivative (XII), which is coupled to O-t-butylhydroxylamine hydrochloride by means of HOBt, N-methylmorpholine and N-[dimethylaminopropyl]-N'-ethylcarbodiimide hydrochloride (EDC·HCl) in CH2Cl2. Finally, removal of the t-Bu group with HCl (gas) in dichloroethane/EtOH yields the desired compound.

1 Parker, D.T. (Novartis AG); alpha-Substd. arylsulphonamido hydroxamic acids as TNF-alpha and matrix metalloproteinase inhibitors. EP 0873312; JP 2000502088; US 5770624; WO 9722587 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 31690 (2R)-2-amino-2-(4-hydroxyphenyl)ethanoic acid; (2R)-2-(4-hydroxyphenyl)glycine; D-(-)-p-Hydroxyphenylglycine; (R)-2-amino-2-(4-hydroxyphenyl)acetic acid 22818-40-2 C8H9NO3 详情 详情
(II) 45921 (2R)-2-amino-2-(4-hydroxycyclohexyl)ethanoic acid C8H15NO3 详情 详情
(III) 45922 4-ethoxybenzenesulfonyl chloride C8H9ClO3S 详情 详情
(IV) 45923 (2R)-2-[[(4-ethoxyphenyl)sulfonyl]amino]-2-(4-hydroxycyclohexyl)ethanoic acid C16H23NO6S 详情 详情
(V) 12912 1-(Bromomethyl)benzene; Alpha-bromotoluene 100-39-0 C7H7Br 详情 详情
(VI) 45924 benzyl (2R)-2-[[(4-ethoxyphenyl)sulfonyl]amino]-2-(4-hydroxycyclohexyl)ethanoate C23H29NO6S 详情 详情
(VII) 45925 benzyl (2R)-2-[[(4-ethoxyphenyl)sulfonyl]amino]-2-(4-oxocyclohexyl)ethanoate C23H27NO6S 详情 详情
(VIII) 29338 1-propanol 71-23-8 C3H8O 详情 详情
(IX) 45926 benzyl (2R)-2-[[(4-ethoxyphenyl)sulfonyl]amino]-2-(4-propoxycyclohexyl)ethanoate C26H35NO6S 详情 详情
(X) 10844 4-(Chloromethyl)pyridine 10445-91-7 C6H6ClN 详情 详情
(XI) 45927 benzyl (2R)-2-[[(4-ethoxyphenyl)sulfonyl](4-pyridinylmethyl)amino]-2-(4-propoxycyclohexyl)ethanoate C32H40N2O6S 详情 详情
(XII) 45928 (2R)-2-[[(4-ethoxyphenyl)sulfonyl](4-pyridinylmethyl)amino]-2-(4-propoxycyclohexyl)ethanoic acid C25H34N2O6S 详情 详情

合成路线4

该中间体在本合成路线中的序号:(III)

The known 3,5-dimethylpyrrole-2,4-dicarboxylic acid 2-benzyl ester 4-t-butyl ester (I) is subjected to benzyl group hydrogenolysis over Pd/C to provide the corresponding pyrrole-2-carboxylic acid (II). Subsequent coupling of acid (II) with 1-propanol (III) in the presence of trifluoroacetic anhydride furnishes the 2-propyl ester (IV). The 4-t-butyl ester of (IV) is then cleaved by means of trifluoroacetic acid, yielding the pyrrole-4-carboxylic acid (V). This is finally coupled to 3,3-dimethyl-2-butanol (VI) by using trifluoroacetic anhydride to furnish the target pyrrole diester.

1 Synthesis and pharmacological characterisation of 2,4-dicarboxy-pyrroles as selective non-competitive mGluR1 antagonists. Bioorg Med Chem 2003, 11, 2, 171.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 65095 2-benzyl 4-(tert-butyl) 3,5-dimethyl-1H-pyrrole-2,4-dicarboxylate C19H23NO4 详情 详情
(II) 65096 4-(tert-butoxycarbonyl)-3,5-dimethyl-1H-pyrrole-2-carboxylic acid C12H17NO4 详情 详情
(III) 29338 1-propanol 71-23-8 C3H8O 详情 详情
(IV) 65097 4-(tert-butyl) 2-propyl 3,5-dimethyl-1H-pyrrole-2,4-dicarboxylate C15H23NO4 详情 详情
(V) 65098 2,4-dimethyl-5-(propoxycarbonyl)-1H-pyrrole-3-carboxylic acid C11H15NO4 详情 详情
(VI) 65099 3,3-dimethyl-2-butanol C6H14O 详情 详情

合成路线5

该中间体在本合成路线中的序号:(I)

 

1 Wang YC, Shi DQ, Zhao H et aL.2001. Synthesis of meloxicam. 中国医药工业杂志.32: 244~245
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 29338 1-propanol 71-23-8 C3H8O 详情 详情
(II) 15966 propionaldehyde 123-38-6 C3H6O 详情 详情
(III) 66520 3,3-dibromopropanal   C3H4Br2O 详情 详情
(IV) 19538 5-Methyl-2-thiazolamine; 5-methyl-1,3-thiazol-2-ylamine; 5-methyl-1,3-thiazol-2-amine; 2-amino-5-methylthiazole 7305-71-7 C4H6N2S 详情 详情
(V) 19537 methyl 4-hydroxy-2-methyl-1,1-dioxo-1,2-dihydro-1lambda(6),2-benzothiazine-3-carboxylate C11H11NO5S 详情 详情
Extended Information